Panacea Biotec (BOM:531349) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec 3-Year Dividend Growth Rate?

Panacea Biotec's Dividends per Share for the three months ended in Dec. 2024 was ₹0.00.

The historical rank and industry rank for Panacea Biotec's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Panacea Biotec was -9.10% per year. The lowest was -37.00% per year. And the median was -12.60% per year.

BOM:531349's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 8.65
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Panacea Biotec's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Panacea Biotec's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Panacea Biotec's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Panacea Biotec's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Biotec's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's 3-Year Dividend Growth Rate falls into.

Save Embed

;

Save Embed

;

Panacea Biotec 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Panacea Biotec (BOM:531349) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Panacea Biotec's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2024 )	/	EPS without NRI (Q: Dec. 2024 )
	=	0	/	0.423
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Biotec 3-Year Dividend Growth Rate Related Terms>

Panacea Biotec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines